Xconomy: vaccines News, Articles and Opinions

“vaccines” Archives

Entry	Author	Date	Location
Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall	Ben Fidler	10/19/15	Boston
Genocea Climbs on Follow-Up Data for Herpes Vaccine	Ben Fidler	10/07/15	Boston
CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard	Ben Fidler	09/10/15	Boston
Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round	Ben Fidler	09/08/15	Boston
With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines	Alex Lash	07/23/15	San Francisco
Biopharmaceutical Haiku, Round Two	Stewart Lyman	07/06/15	Seattle
Selecta Takes Nanotech to Gene Therapy, Celiac With New Deals	Ben Fidler	05/13/15	Boston
Big Apple Biotech “Bootstraps” Forward at NewYorkBio Meeting	Ben Fidler	05/05/15	New York
Vaxxas Gets $20M Injection to Test Needle-Free Vaccines in Humans	Ben Fidler	02/09/15	Boston
More Green For Moderna as Merck Makes $50M Equity Grab, mRNA Deal	Ben Fidler	01/13/15	Boston
Moderna Forms Latest Venture, Valera, to Fight Infections With mRNA	Ben Fidler	01/08/15	Boston
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile	Angela Shah	12/22/14	Texas
Accelerate LI’s Latest Startup Aims to Rewire Viruses With Software	Ben Fidler	12/16/14	New York
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More	Ben Fidler	10/31/14	Boston
Backed by Gates, Affinivax Ramps up Velcro-like Vaccine Tech	Ben Fidler	10/30/14	Boston
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer	Ben Fidler	10/15/14	Boston
An Intriguing Program Takes on Tropical Diseases—But Not Ebola	Alex Lash	09/10/14	National
West Coast Biotech Roundup: Amgen Layoffs, Avalanche, Venter & More	Alex Lash	07/31/14	Seattle
Get a Shot, Have Some Bread: ImmusanT’s Plan For a Celiac Vaccine	Ben Fidler	03/11/14	Boston
Seattle BioMed Nabs $10M NIAID Grant to Develop HIV Vaccines	Ben Fidler	03/10/14	Seattle
Vaccine Developer Genocea Prices IPO at $12 Per Share	Ben Fidler	02/05/14	Boston
Using Cutting-Edge Science and Technology Against an Age-Old Disease	Steve Reed	01/24/14	Seattle
Madison Vaccines Closes $8M Series A Round for Prostate Treatment	Jeff Engel	01/13/14	Wisconsin
Vaccine Developer Genocea Files For IPO, Plans to Raise $75M	Ben Fidler	12/23/13	Boston
IDRI CEO Stewart Parker Steps Down, Erik Iverson Steps Up	Luke Timmerman	12/19/13	Seattle
San Diego Life Sciences Roundup: Rempex, Pfenex, Halozyme & More	Bruce V. Bigelow	12/19/13	San Diego
What Was Hyped, and What Fell Out of Favor, This Year in Biotech	Luke Timmerman	12/16/13	National
Gates Foundation Health Chief on Coaxing Pharma to Do Good (Part 2)	Luke Timmerman	11/26/13	National
Gates Foundation Health Chief on Coaxing Pharma to Do Good	Luke Timmerman	11/25/13	National
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely	Bernadette Tansey	10/01/13	San Francisco
Page 2 of 10	« previous page · next page »